The Treatment of Ocular Adnexal Extranodal Marginal Zone B-cell Lymphoma by Orelabrutinib and Radiotherapy
Clinical trial NCT06503276 · RECRUITING
Trial details
- NCT number
- NCT06503276
- Sponsor
- Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-01
- Primary completion
- 2025-10-31
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.